IMUX
Immunic·NASDAQ
--
--(--)
--
--(--)
IMUX fundamentals
Immunic (IMUX) released its earnings on Aug 7, 2025: revenue was 0 (YoY --), met estimates; EPS was -0.2 (YoY +4.76%), missed estimates.
Revenue / YoY
0
--
EPS / YoY
-0.2
+4.76%
Report date
Aug 7, 2025
Earnings Call
6:30 AM on Aug 7, 2025
Meeting link.Earnings
EPS
Revenue
Revenue & Expenses
Key Indicators
Immunic (IMUX) key financial stats and ratios, covering profitability, financial health, and leverage.
Income Statement
Immunic (IMUX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Balance Sheet
Immunic (IMUX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Cash Flow
Immunic (IMUX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Revenue Breakdown
Where does Immunic (IMUX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Dividend
Track Immunic (IMUX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Immunic year over year?What guidance did Immunic's management provide for the next earnings period?What is Immunic's gross profit margin?What factors drove the changes in Immunic's revenue and profit?What does Immunic do and what are its main business segments?What is Immunic's latest dividend and current dividend yield?What were the key takeaways from Immunic's earnings call?What were the key takeaways from Immunic’s earnings call?
